Welcome!

News Feed Item

Migraine Global Clinical Trials Review, H2, 2013

NEW YORK, Oct. 23, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Migraine Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0681715/Migraine-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

Migraine Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, "Migraine Global Clinical Trials Review, H2, 2013" provides data on the Migraine clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Migraine. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Migraine. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Migraine 6
Report Guidance 6

Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Migraine 23
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Migraine Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33

Merck & Co., Inc. 33
Clinical Trial Overview of Merck & Co., Inc. 33
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Johnson & Johnson 39
Clinical Trial Overview of Johnson & Johnson 39
Allergan, Inc. 42
Clinical Trial Overview of Allergan, Inc. 42
AstraZeneca PLC 44
Clinical Trial Overview of AstraZeneca PLC 44
Pfizer Inc. 46
Clinical Trial Overview of Pfizer Inc. 46
Banyan Group, Inc. 48
Clinical Trial Overview of Banyan Group, Inc. 48
NuPathe Inc. 49
Clinical Trial Overview of NuPathe Inc. 49
Endo Health Solutions Inc. 50
Clinical Trial Overview of Endo Health Solutions Inc. 50

Alexza Pharmaceuticals, Inc. 51
Clinical Trial Overview of Alexza Pharmaceuticals, Inc. 51
Clinical Trial Overview of Top Institutes / Government 52
Danish Headache Center 52
Clinical Trial Overview of Danish Headache Center 52
Thomas Jefferson University 54
Clinical Trial Overview of Thomas Jefferson University 54
Montefiore Medical Center 55
Clinical Trial Overview of Montefiore Medical Center 55
Johns Hopkins University 56
Clinical Trial Overview of Johns Hopkins University 56
The Cleveland Clinic 57
Clinical Trial Overview of The Cleveland Clinic 57
Chengdu University of Traditional Chinese Medicine 58
Clinical Trial Overview of Chengdu University of Traditional Chinese Medicine 58
University of Pittsburgh 59
Clinical Trial Overview of University of Pittsburgh 59
Glostrup University Hospital 60
Clinical Trial Overview of Glostrup University Hospital 60
Shahid Beheshti University 61
Clinical Trial Overview of Shahid Beheshti University 61
Swedish Medical Center 62
Clinical Trial Overview of Swedish Medical Center 62

Five Key Clinical Profiles 63
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 112


List of Tables
Migraine Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Migraine Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Migraine Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Migraine Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Migraine Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
Migraine Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Migraine Therapeutics Clinical Trials, G7 Countries, 2013* 16
Migraine Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Migraine Therapeutics Clinical Trials, E7 Countries, 2013* 18
Migraine Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Migraine Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21

Migraine Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Migraine Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
Migraine Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
Migraine Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25
Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Migraine Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 33
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 36
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 39
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2013* 42
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 44
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 46
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Banyan Group, Inc., 2013* 48

Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by NuPathe Inc., 2013* 49
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Health Solutions Inc., 2013* 50
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexza Pharmaceuticals, Inc., 2013* 51
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish Headache Center, 2013* 52
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2013* 54
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Montefiore Medical Center, 2013* 55
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 56
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2013* 57
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu University of Traditional Chinese Medicine, 2013* 58
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 59
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Glostrup University Hospital, 2013* 60
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University, 2013* 61
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Swedish Medical Center, 2013* 62

List of Figures
Migraine Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Migraine Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Migraine Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Migraine Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13
Migraine Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14
Migraine Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Migraine Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Migraine Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Migraine Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Migraine Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Migraine Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Migraine Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Migraine Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
GlobalData Methodology 110

To order this report: Migraine Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0681715/Migraine-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

__________________________
Contact Clare: [email protected]
US: (339)-368-6001

Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The WebRTC Summit New York, to be held June 6-8, 2017, at the Javits Center in New York City, NY, announces that its Call for Papers is now open. Topics include all aspects of improving IT delivery by eliminating waste through automated business models leveraging cloud technologies. WebRTC Summit is co-located with 20th International Cloud Expo and @ThingsExpo. WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web co...
For basic one-to-one voice or video calling solutions, WebRTC has proven to be a very powerful technology. Although WebRTC’s core functionality is to provide secure, real-time p2p media streaming, leveraging native platform features and server-side components brings up new communication capabilities for web and native mobile applications, allowing for advanced multi-user use cases such as video broadcasting, conferencing, and media recording.
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
SYS-CON Events announced today that Enzu will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Enzu’s mission is to be the leading provider of enterprise cloud solutions worldwide. Enzu enables online businesses to use its IT infrastructure to their competitive ad...
"Plutora provides release and testing environment capabilities to the enterprise," explained Dalibor Siroky, Director and Co-founder of Plutora, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
DevOps tends to focus on the relationship between Dev and Ops, putting an emphasis on the ops and application infrastructure. But that’s changing with microservices architectures. In her session at DevOps Summit, Lori MacVittie, Evangelist for F5 Networks, will focus on how microservices are changing the underlying architectures needed to scale, secure and deliver applications based on highly distributed (micro) services and why that means an expansion into “the network” for DevOps.
"We are an all-flash array storage provider but our focus has been on VM-aware storage specifically for virtualized applications," stated Dhiraj Sehgal of Tintri in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Choosing the right cloud for your workloads is a balancing act that can cost your organization time, money and aggravation - unless you get it right the first time. Economics, speed, performance, accessibility, administrative needs and security all play a vital role in dictating your approach to the cloud. Without knowing the right questions to ask, you could wind up paying for capacity you'll never need or underestimating the resources required to run your applications.
Web Real-Time Communication APIs have quickly revolutionized what browsers are capable of. In addition to video and audio streams, we can now bi-directionally send arbitrary data over WebRTC's PeerConnection Data Channels. With the advent of Progressive Web Apps and new hardware APIs such as WebBluetooh and WebUSB, we can finally enable users to stitch together the Internet of Things directly from their browsers while communicating privately and securely in a decentralized way.
WebRTC is about the data channel as much as about video and audio conferencing. However, basically all commercial WebRTC applications have been built with a focus on audio and video. The handling of “data” has been limited to text chat and file download – all other data sharing seems to end with screensharing. What is holding back a more intensive use of peer-to-peer data? In her session at @ThingsExpo, Dr Silvia Pfeiffer, WebRTC Applications Team Lead at National ICT Australia, looked at differ...
Adding public cloud resources to an existing application can be a daunting process. The tools that you currently use to manage the software and hardware outside the cloud aren’t always the best tools to efficiently grow into the cloud. All of the major configuration management tools have cloud orchestration plugins that can be leveraged, but there are also cloud-native tools that can dramatically improve the efficiency of managing your application lifecycle. In his session at 18th Cloud Expo, ...
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.
The security needs of IoT environments require a strong, proven approach to maintain security, trust and privacy in their ecosystem. Assurance and protection of device identity, secure data encryption and authentication are the key security challenges organizations are trying to address when integrating IoT devices. This holds true for IoT applications in a wide range of industries, for example, healthcare, consumer devices, and manufacturing. In his session at @ThingsExpo, Lancen LaChance, vic...
With the proliferation of both SQL and NoSQL databases, organizations can now target specific fit-for-purpose database tools for their different application needs regarding scalability, ease of use, ACID support, etc. Platform as a Service offerings make this even easier now, enabling developers to roll out their own database infrastructure in minutes with minimal management overhead. However, this same amount of flexibility also comes with the challenges of picking the right tool, on the right ...
With all the incredible momentum behind the Internet of Things (IoT) industry, it is easy to forget that not a single CEO wakes up and wonders if “my IoT is broken.” What they wonder is if they are making the right decisions to do all they can to increase revenue, decrease costs, and improve customer experience – effectively the same challenges they have always had in growing their business. The exciting thing about the IoT industry is now these decisions can be better, faster, and smarter. Now ...